Application 201464
- Type
- ANDA
- Sponsor
- PHARMADAX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM | LEVETIRACETAM | TABLET, EXTENDED RELEASE;ORAL | 500MG | No | No |
| 002 | LEVETIRACETAM | LEVETIRACETAM | TABLET, EXTENDED RELEASE;ORAL | 750MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 52817-110 | levetiracetam | levetiracetam | Trupharma, LLC | ANDA | Current |
| 52817-110 | levetiracetam | levetiracetam | Trupharma, LLC | ANDA | Current |
| 52817-111 | levetiracetam | levetiracetam | Trupharma, LLC | ANDA | Current |
| 52817-111 | levetiracetam | levetiracetam | Trupharma, LLC | ANDA | Current |
| 64376-697 | Levetiracetam | Levetiracetam | Par Pharmaceutical | ANDA | Current |
| 75834-245 | LEVETIRACETAM EXTENDED RELEASE | LEVETIRACETAM | Nivagen Pharmaceuticals, Inc. | ANDA | Current |
| 75834-246 | LEVETIRACETAM EXTENDED RELEASE | LEVETIRACETAM | Nivagen Pharmaceuticals, Inc. | ANDA | Current |